NCT03244956
- Conditions
- Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
- Locations
-
- Gustave Roussy Villejuif, Val de Marne, France
Clinical trial condition
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
Explore clinical trials studying Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies